"An independent clinical research center partnering with local physicians in Missoula, MT."

During the past decade, Montana Medical Research conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 29 clinical trials were completed, i.e. on average, 93.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 21 clinical trials were completed. i.e. 105% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montana Medical Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Allergan" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Novartis Pharmaceuticals" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montana Medical Research" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Montana Medical Research" are "Asthma" (4 trials), "Gastroparesis" (4 trials), "Chronic Obstructive Pulmonary Disease" (3 trials), "Diabetes Mellitus" (3 trials) and "Migraine" (3 trials). Many other conditions were trialed in "Montana Medical Research" in a lesser frequency.

Most popular intervention types in "Montana Medical Research" are "Drug" (48 trials), "Biological" (5 trials), "Other" (5 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "placebo" (4 trials), "Dihydroergotamine" (3 trials), "Relamorelin" (3 trials) and "BLU-5937" (2 trials). Other intervention names were less common.

The vast majority of trials in "Montana Medical Research" are 50 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Montana Medical Research". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Montana Medical Research, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Montana Medical Research, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".